news
NICE recommends Kisqali as a cost-effective treatment for advanced breast cancer
NICE recommends Kisqali as a cost-effective treatment option for postmenopausal women within England and Wales with advanced breast cancer...
List view / Grid view
Breast cancer
news
Nanoshells could deliver more chemo with fewer side effects
In vitro study verifies method for remotely triggering release of cancer drugs...
news
Combined therapies increase side effects for patients with advanced breast cancer
Patients with advanced breast cancer who are treated with a combination of drugs are at increased risk of suffering adverse side effects...
news
CYC065-eribulin combination for triple-negative breast cancer identified
Researchers find novel combination disrupts multiple factors in aggressive breast cancer...
news
Poliovirus therapy induces immune responses against cancer
Investigational therapy directly kills tumour cells and unmasks them to the body's defences.
news
MRI effective in detecting postpartum breast cancers
Pregnancy-associated breast cancer, which is rare but often aggressive, has been detected with MRI...
news
FDA approves first biosimilar for the treatment of cancer
Mvasi, a biosimilar to the cancer drug Avastin, is approved for certain colorectal, lung, brain, kidney and cervical cancers…
news
Taselisib boosts breast tumour shrinkage
According to results of the LORELEI clinical trial, adding taselisib to letrozole before surgery significantly improved outcomes for patients with early breast cancer...
news
Z-endoxifen shows promise for breast cancer
Z-endoxifen, a potent derivative of the drug tamoxifen, could itself be a new treatment for the most common form of breast cancer...
news
Immunotherapy combination effective at killing cancer cells
Researchers have recently discovered an immunotherapy that uses existing cancer drugs in a whole new way...
news
Metal simplifies synthesis of antibody drugs
Scientists have developed a method to efficiently modify natural antibodies that can deliver drugs to target cells...
news
Novartis receives EU approval for ribociclib
Novartis announced that the European Commission approved ribociclib in combination with an aromatase inhibitor for treatment of postmenopausal women with metastatic breast cancer
news
Cancer Research UK launches trial to test new drug
A clinical trial to test a new cancer drug in patients with advanced solid tumours, launches in four centres across the UK...
news
New imaging technique may predict the spread of breast cancer
Researchers have developed a new imaging technique to detect myeloid-derived suppressor cells’ accumulating in the lung...
news
Kadcyla new deal means NICE positive recommendation in draft guidance
A new deal on the breast cancer drug trastuzumab emtansine means that it can now be recommended for routine funding.
